The Expanding Osteoporosis Market: Potential of Current and New DrugsDecision ResourcesSeptember 29, 2005 16 Pages - SKU: DECR1212094 |
|
Osteoarthritis Pain Global Clinical Trials Review, H1, 2012
3/31/2012 | published by: GlobalData
Osteoarthritis Pain Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Osteoarthritis Pain Global Clinical Trials Review, H1, 2012 provides data on the Osteoarthritis Pain clinical trial scenario. This report provides elemental information and data
|
more...
|
$1,000.00
|
|
Post Menopausal Osteoporosis Global Clinical Trials Review, H1, 2012
2/20/2012 | published by: GlobalData
Post Menopausal Osteoporosis Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Post Menopausal Osteoporosis Global Clinical Trials Review, H1, 2012 provides data on the Post Menopausal Osteoporosis clinical trial scenario. This report provides elemental
|
more...
|
$1,000.00
|
|
Osteoporosis Therapeutics - Pipeline Assessment and Market Forecasts to 2018
12/19/2011 | published by: GlobalData
Osteoporosis Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Summary GlobalData, the industry analysis specialist, has released its new report, “Osteoporosis Therapeutics - Pipeline Assessment and Market Forecasts to 2018”. The report is an essential source
|
more...
|
$3,500.00
|
|
Osteoporosis – Pipeline Review, H1 2012
2/27/2012 | published by: Global Markets Direct
Osteoporosis – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Osteoporosis - Pipeline Review, H1 2012', provides an overview of the Osteoporosis therapeutic pipeline. This report provides information on the therapeutic development for Osteoporosis, complete with latest
|
more...
|
$500.00
|
|
Osteoarthritis (OA) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
11/30/2011 | published by: GlobalData
Osteoarthritis (OA) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Summary GlobalData, the industry analysis specialist, has released its new report, “Osteoarthritis (OA) Therapeutics - Pipeline Assessment and Market Forecasts to 2018”. The report is an
|
more...
|
$3,500.00
|
|
The Women's Health Market Outlook to 2016
5/31/2011 | published by: Business Insights
Introduction The Women’s Health Market Outlook to 2016 provides comprehensive coverage of the women’s health market, a incorporating disease overview and detailed epidemiological analyses of the major indications. This report makes an in-depth assessment of marketed
|
more...
|
$3,835.00
|
|
Epidemiology: Osteopenia and Osteoporosis - On the rise as the aging population grows
7/8/2011 | published by: Datamonitor
Introduction The prevalence of hip fractures, a condition related to osteopenia and osteoporosis, increased during the latter half of the 20th century but has since leveled off or decreased in most markets. The current combined prevalence
|
more...
|
$5,700.00
|
|
Key Companies: Osteoporosis - Growing competition threatens leading franchises and drives innovation
7/21/2011 | published by: Datamonitor
Introduction The osteoporosis market is dominated by large pharmaceutical companies that can leverage their considerable financial reserves to conduct large-scale clinical trials, and which have the marketing strength needed to penetrate this sector. Osteoporosis companies market
|
more...
|
$3,800.00
|
|
Global Osteoporosis Market & Drugs Analysis 2010 - 2015
9/1/2011 | published by: Renub Research
Osteoporosis Market Overview
Osteoporosis is often called the ""silent disease"" because bone loss occurs without symptoms. It is characterized by low bone mass and micro-architectural deterioration of bone tissue, leading to
|
more...
|
$950.00
|
|
Osteoarthritis - Pipeline Review, H2 2011
9/28/2011 | published by: Global Markets Direct
Osteoarthritis - Pipeline Review, H2 2011 Summary Global Markets Direct’s, 'Osteoarthritis - Pipeline Review, H2 2011', provides an overview of the Osteoarthritis therapeutic pipeline. This report provides information on the therapeutic development for Osteoarthritis, complete with latest
|
more...
|
$500.00
|
Related Markets
Osteoporosis Reports
- Osteoarthritis Pain Global Clinical Trials Review, H1, 2012
- Post Menopausal Osteoporosis Global Clinical Trials Review, H1, 2012
- Osteoporosis Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Osteoarthritis (OA) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Osteoporosis Global Clinical Trials Review, H2, 2011
